FPL 55712
FPL 55712 structure
|
Common Name | FPL 55712 | ||
|---|---|---|---|---|
| CAS Number | 40786-08-1 | Molecular Weight | 520.50400 | |
| Density | 1.314g/cm3 | Boiling Point | 716.9ºC at 760 mmHg | |
| Molecular Formula | C27H29NaO9 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 238.2ºC | |
Use of FPL 55712FPL-55712 is a CysLT1 leukotriene receptor antagonist. |
| Name | FPL 55712,7-[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylicacid |
|---|
| Density | 1.314g/cm3 |
|---|---|
| Boiling Point | 716.9ºC at 760 mmHg |
| Molecular Formula | C27H29NaO9 |
| Molecular Weight | 520.50400 |
| Flash Point | 238.2ºC |
| Exact Mass | 520.17100 |
| PSA | 146.33000 |
| LogP | 2.78840 |
| Index of Refraction | 1.6 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Strategies in the design of peptidoleukotriene antagonists.
J. Lipid Mediat. 6(1-3) , 265-73, (1993) The research of the last two decades in the field of SRS-A and peptidoleukotriene (pLT) antagonists has provided information for the design of potent pLT antagonists, which share some or all of the fo... |
|
|
Leukotriene receptor blockade in experimental heart failure.
Res. Exp. Med. (Berl.) 197(4) , 177-87, (1997) The pathophysiological role of endogenous leukotrienes in cardiovascular control and the regulation of renal function in congestive heart failure is not known. Therefore, in six conscious dogs with or... |
|
|
Leukotriene cysLT1 (LTD4) receptor antagonism of H1-antihistamines: an in vitro study.
Inflamm. Res. 46 Suppl 1 , S93-4, (1997)
|